Related references
Note: Only part of the references are listed.Celastrus and Its Bioactive Celastrol Protect against Bone Damage in Autoimmune Arthritis by Modulating Osteoimmune Cross-talk
Siddaraju M. Nanjundaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Nicotine-Induced Differential Modulation of Autoimmune Arthritis in the Lewis Rat Involves Changes in Interleukin-17 and Anti-Cyclic Citrullinated Peptide Antibodies
Hua Yu et al.
ARTHRITIS AND RHEUMATISM (2011)
Herbal medicinal products target defined biochemical and molecular mediators of inflammatory autoimmune arthritis
Shivaprasad H. Venkatesha et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Suppression of Ongoing Experimental Arthritis by a Chinese Herbal Formula (Huo-Luo-Xiao-Ling Dan) Involves Changes in Antigen-Induced Immunological and Biochemical Mediators of Inflammation
Ying-Hua Yang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
Interleukin-27 and Interferon-γ Are Involved in Regulation of Autoimmune Arthritis
Rajesh Rajaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Role of Osteopontin in Synovial Th17 Differentiation in Rheumatoid Arthritis
Guangjie Chen et al.
ARTHRITIS AND RHEUMATISM (2010)
Discovery of cyclooxygenase inhibitors from medicinal plants used to treat inflammation
Hongmei Cao et al.
PHARMACOLOGICAL RESEARCH (2010)
Specifically Modified Osteopontin in Rheumatoid Arthritis Fibroblast-like Synoviocytes Supports Interaction With B Cells and Enhances Production of Interleukin-6
Yasuhiro Take et al.
ARTHRITIS AND RHEUMATISM (2009)
Persistent low grade synovitis without erosive progression in magnetic resonance imaging of rheumatoid arthritis patients treated with infliximab over 1 year
Joao Eurico Fonseca et al.
CLINICAL RHEUMATOLOGY (2009)
Huo-Luo-Xiao-Ling Dan modulates antigen-directed immune response in adjuvant-induced inflammation
Rajesh Rajaiah et al.
JOURNAL OF ETHNOPHARMACOLOGY (2009)
Extract of the Chinese herbal formula Huo Luo Xiao Ling Dan inhibited adjuvant arthritis in rats
Rui-Xin Zhang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2009)
GM-CSF Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway
Myeung Su Lee et al.
JOURNAL OF IMMUNOLOGY (2009)
Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells
J. Dai et al.
ONCOGENE (2009)
Functions of RANKL/RANK/OPG in bone modeling and remodeling
Brendan F. Boyce et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Immune-mediated pathways in chronic inflammatory arthritis
Claire L. Gorman et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2008)
Two Kampo medicines, Jidabokuippo and Hachimijiogan alleviate sprains, bruises and arthritis
Yasuyo Hijikata et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2007)
Natural products as a gold mine for arthritis treatment
Dinesh Khanna et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43
Dong Jin Chung et al.
JOURNAL OF CELL SCIENCE (2006)
Anti-hyperalgesic and anti-inflammatory effects of the modified Chinese herbal formula Huo Luo Xiao Ling Dan (HLXL) in rats
Lixing Lao et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2006)
Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement - A detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study
JS Smolen et al.
ARTHRITIS AND RHEUMATISM (2005)
The role of complementary and alternative therapies in managing rheumatoid arthritis
DM Taibi et al.
FAMILY & COMMUNITY HEALTH (2003)
Role of RANKL and RANK in bone loss and arthritis
DH Jones et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Bone destruction in arthritis
EM Gravallese
ANNALS OF THE RHEUMATIC DISEASES (2002)
Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis - Possible involvement of osteopontin in bone destruction in arthritis
S Ohshima et al.
ARTHRITIS AND RHEUMATISM (2002)
Infliximab and methotrexate in the treatment of rheumatoid arthritis
PE Lipsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development
JE Fata et al.
CELL (2000)
IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion
E Lubberts et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)